Skip to main
Skip to main
University-wide Navigation
google search home screen on cell phone

Research Publications - August 2020

UK College of Pharmacy
 Sep 3, 2020
Research
  1. Rosovsky RP, Grodzin C, Channick R, Davis GA, Giri JS, Horowitz J, Kabrhel C, Lookstein R, Merli G, Morris TA, Rivera-Lebron B, Tapson V, Todoran TM, Weinberg AS, Rosenfield K, PERT Consortium. (2020). Diagnosis and treatment of pulmonary embolism during the COVID-19 pandemic: A position paper from the national PERT Consortium. Chest, doi: 10.1016/j.chest.2020.08.2064.

 

  1. Clinger JA, Wang X, Cai W, Zhu Y, Miller MD, Zhan CG, Van Lanen S, Thorson JS, Phillips Jr GN. (2020). The crystal structure of AbsH3: A putative FAD-dependent reductase in abyssomicin biosynthesis pathway. Proteins, doi: 10.1002/prot.25994.

 

  1. Eagon S, Hammill JT, Bach J, Everson N, Sisley TA, Walls MJ, Durham S, Pillai DR, Falade MO, Rice AL, Kimball JJ, Lazaro H, DiBernardo C, Guy RK. (2020). Antimalarial activity of tetrahydro-b-carbolines targeting the ATP binding pocket of the Plasmodium falciparum heat shock 90 protein. Bioorg Med Chem Lett, doi: 10.1016/j.bmcl.2020.127502.

 

  1. Asgari M, Gazor R, Abdollahifar MA, Fathabady FF, Zare F, Norousian M, Amini A, Khosravipour A, Kiani P, Atashgah RB, Rezaei F, Ghoreishi SK, Chien S, Hamblin MR, Bayat M. (2020). Combined therapy of adipose-derived stem cells and photobiomodulation on accelerated bone healing of a critical size defect in an osteoporotic rat model. Biochem Biophys Res Commun, doi: 10.1016/j.bbrc.2020.06.023.

 

  1. Bardgett ME, Downnen T, Crane C, Baltes Thompson EC, Muncie B, Steffen SA, Yates JR, Pauly JR. (2020). Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference. Neuropharmacology, doi: 10.1016/j.neuropharm.2020.108276.

 

  1. Cooper HLF, Cloud DH, Young AM, Freeman PR. (2020). When prescribing isn’t enough – Pharmacy-level barriers to buprenorphine access. N Engl J Med, doi: 10.1056/NEJMp2002908.

 

  1. Larson K, Huang B, Chen Q, Tucker T, Schuh M, Arnold SM, Kolesar JM. (2020). EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky. PLoS One, doi: 10.1371/journal.pone.0237790.

 

  1. Zamarripa CA, Patel TR, Williams BC, Pareek T, Shrock HM, Prisinzano TE, Freeman KB. (2020). The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone’s conditioned rewarding effects in male rats. Behav Pharmacol, doi: 10.1097/FBP.0000000000000581.

 

  1. McNamara PJ, Meiman D. (2020). Predicting drug binding to human serum albumin and alpha one acid glycoprotein in diseased and age patient populations. J Pharm Sci, doi: 10.1016/j.xphs.2019.03.018.

 

  1. Johnson E, Ii RP, Nelson G, Elias K, Kramer B, Gaviola M. (2020). Expanding pharmacotherapy data collection, analysis, and implementation in ERAS-Pragrams – The methodology of an exploratory feasibility study. Healthcare (Basel), doi: 10.2290/healthcare8030252.

 

  1. Cook AM, Cook TS, Rosen-Lamer A. (2020). Errors with extemporaneous compounding of buffered hypertonic saline. Am J Health Syst Pharm, doi: 10/1093/ajhp/zxaa226.

 

  1. Pitts MG, Nardo D, Ison CM, Venditto VJ. (2020). Autoantibody responses to apolipoprotein A-1 are not diet- or sex-linked in C57BL/6 mice. Immunohorizons, doi: 10.4049/immunohorizons.2000027.
Important Information
Phone: (859) 323-7601
Emergencies: 911, #UKPD (#8573)
UKPD Main Dispatch: (859) 257-1616
Environmental Health & Safety: (859) 257-3827
University of Kentucky Homepage A link to return to the University of Kentucky Homepage
An Equal Opportunity University
Accreditation
Directory
Email
Privacy Policy
Accessibility
Disclosures
© University of Kentucky
Lexington, Kentucky 40506